id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1999-D-3528-0007,FDA,FDA-1999-D-3528,"Changes to an Approved Application: Biological Products: Human Blood and Blood Components Intended for Transfusion or for Further
Manufacture; Guidance for Industry",Other,Guidance,2014-12-01T05:00:00Z,2014,12,2014-12-01T05:00:00Z,,2024-11-12T05:32:09Z,,1,0,090000648193e846
FDA-1999-D-3528-0006,FDA,FDA-1999-D-3528,"Changes to an Approved Application: Biological Products: Human Blood and Blood Components Intended for Transfusion or for Further
Manufacture; Guidance for Industry; Availability",Notice,Notice of Availability,2014-11-21T05:00:00Z,2014,11,2014-11-21T05:00:00Z,,2014-11-21T18:56:20Z,2014-27521,0,0,090000648193d6f2
FDA-1999-D-3528-0002,FDA,FDA-1999-D-3528,Guidance for Industry Changes to an Approved Application: Biological Products: Human Blood and Blood Components Intended for Transfusion or for Further Manufacture,Other,Guidance,2013-05-31T04:00:00Z,2013,5,2013-05-31T04:00:00Z,2013-06-02T03:59:59Z,2020-04-24T03:31:32Z,,0,0,0900006481305608
FDA-1999-D-3528-0001,FDA,FDA-1999-D-3528,Draft Guidance for Industry; Changes to an Approved Application: Biological Products: Human Blood and Blood Components Intended for Transfusion or for Further Manufacture; Availability,Notice,Notice of Availability,2013-05-31T04:00:00Z,2013,5,2013-05-31T04:00:00Z,2013-08-30T03:59:59Z,2013-08-30T01:16:59Z,2013-12923,0,0,09000064813041ce